News
JAGX
0.1871
+10.06%
0.0171
Why Nucor Shares Are Trading Lower? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Nucor Corporation tumbled 6.5% to $179.20 on Tuesday. The company reported worse-than-expected quarterly financial results. Cyngn Inc. Shares jumped 100% after the company was chosen to supply John Deere with industrial automation. Pineapple Energy Inc. And Virgin Galactic Holdings, Inc. Were among the stocks moving in today's mid-day session.
Benzinga · 2d ago
12 Health Care Stocks Moving In Tuesday's Intraday Session
VolitionRX (AMEX:VNRX) shares rose 33.6% to $0.8 during Tuesday's regular session. Palisade Bio (NASDAQ:PALI) stock increased by 29.81% during the session. Kintara Therapeutics and NKGen Biotech were among the losers.
Benzinga · 3d ago
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers ImmunityBio (NASDAQ:IBRX) shares moved upwards by 32.0% to $6.52 during Tuesday's pre-market session. Nuwellis shares increased by 24.1% and VolitionRX stock increased by 16.66% during the same time period. Losers Abeona Therapeutics and OncoCyte stock declined by 45.7% and 16.34% respectively.
Benzinga · 3d ago
Why Hibbett Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
Shares of Hibbett, Inc. Rose sharply in today's pre-market trading. The company agreed to be acquired by JD Sports Fashion for $87.50 per share in cash. Pineapple Energy Inc. Shares gained 38% to $0.0632 after falling 10% on Monday. ImmunityBio, Inc., AGBA Group Holding Limited and HWH International were among the stocks moving in pre- market trading.
Benzinga · 3d ago
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
HWH International (NASDAQ:HWH) stock is rocketing more than 64% alongside heavy pre-market trading. Pineapple Energy shares are soaring close to 40% on plans to regain listing compliance. The biggest pre- market stock movers on Tuesday morning are delisting updates, proposed public offerings, earnings reports and more.
Investorplace · 3d ago
Jaguar Health Inc Files For Mixed Shelf Offering Of Up To $75M
Benzinga · 3d ago
JAGUAR HEALTH INC FILES FOR MIXED SHELF OFFERING OF UP TO $75 MLN - SEC FILING
Reuters · 3d ago
Why Vaxxinity Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Vaxxinity, Inc. (NASDAQ:VAXX) fell sharply during Monday's mid-day session. The company announced its intention to voluntarily delist and deregister its Class A common stock. Matterport, Inc., shares jumped 184% to $4.93.
Benzinga · 4d ago
Weekly Report: what happened at JAGX last week (0415-0419)?
Weekly Report · 4d ago
S&P 500 Edges Lower; PacBio Shares Plunge
U.S. Stocks traded mixed toward the end of trading on Tuesday. The Dow traded up 0.02% to 37,741.96 while the NASDAQ fell 0.20%. The S&P 500 fell around 0.3% in trading. Information technology shares rose by 0.4% on Tuesday while real estate shares fell by 1.8%. Euro zone European shares closed lower on Tuesday; Asian markets closed lower.
Benzinga · 04/16 18:30
Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Sk Skillsoft Corp. Shares dipped 26.7% to $6.74 on Tuesday. The company reported mixed fourth-quarter financial results and issued FY25 revenue guidance below estimates. WiSA Technologies, Inc. Shares jumped 85% after the company announced a licensing agreement with an HDTV/PTV brand.
Benzinga · 04/16 18:17
Jaguar stock rallies 54% on licensing deal for chemo support drug
Jaguar Health stock rallies 54% on licensing deal for chemo support drug Gelclair in the U.S. Gelclair is used to treat oral mucositis, a painful side effect of certain cancer treatments. The company plans to launch the product in Q3.
Seeking Alpha · 04/16 17:26
12 Health Care Stocks Moving In Tuesday's Intraday Session
Palisade Bio (NASDAQ:PALI) stock increased by 65.1% to $6.87 during Tuesday's regular session. China SXT Pharmaceuticals and Intra-Cellular Therapies were among the gainers. Calidi Biotherapeutics (AMEX:CLDI) shares decreased by 58.5% during the session.
Benzinga · 04/16 16:31
Gold Moves Higher; Morgan Stanley Earnings Top Views
U.S. Stocks traded mixed midway through trading on Tuesday. The Nasdaq Composite fell around 0.2% while the Dow traded up 0.13%. Morgan Stanley reported better-than-expected earnings for its first quarter. Health care shares rose by 0.3% on Tuesday while real estate shares fell by 1.8%. Asian markets closed lower in Asia Pacific markets.
Benzinga · 04/16 16:11
Live Nation Antitrust Probe Rattles LYV Stock. What to Know.
Justice Department is planning to file an antitrust lawsuit against Live Nation Entertainment in the coming weeks. The company is accused of taking part in anticompetitive practices. LYV stock is down 6.8% as a result of the reports. Peraso stock, Jaguar Health stock and Palisade Bio (PALI) are also in the news today.
Investorplace · 04/16 16:03
Why Is Peraso (PRSO) Stock Up 53% Today?
Peraso (NASDAQ:PRSO) stock is up 53% as of Tuesday morning. The semiconductor company announced the adoption of its X710 chipset by Panasonic. More than 52 million shares of PRSO stock have been traded this morning. Shares of Jaguar Health (JAGX), Palisade Bio (PALI) and WiSA Technologies (WISA) are on the rise.
Investorplace · 04/16 15:49
Why Is Jaguar Health (JAGX) Stock Up 44% Today?
Jaguar Health (NASDAQ:JAGX) stock is up 44.3% as of Tuesday morning. The pharmaceutical company announced a new license for a chemo mouth treatment. The company is looking to treat the side effect of chemotherapy with Gelclair. Palisade Bio (PALI), WiSA Technologies (WISA) and BuzzFeed (BZFD) stock are all up on Tuesday.
Investorplace · 04/16 15:34
Jaguar Health Licenses FDA-Approved Oral Mucositis Product For U.S. Market, Initiating Commercial Footprint In Its Core Focus Area Of Cancer Supportive Care; Planning To Begin Commercial Launch In Q3 2024 For Gelclair
Jaguar planning to begin commercial launch in Q3 2024 for Gelclair®, the company's third prescription product Oral mucositis, also called "chemo mouth," has emerged as the most significant adverse event in oncology according to a National Comprehensive Cancer Network task force. Gelclair is a protective gel for the management of pain and relief of pain.
Benzinga · 04/16 12:35
JAGUAR HEALTH INC - AGREEMENT FOR VENTURE LIFE'S FDA-APPROVED ORAL MUCOSITIS PRESCRIPTION PRODUCT, GELCLAIR, FOR U.S. MARKET
Reuters · 04/16 12:34
JAGUAR HEALTH INC - SIGNED EXCLUSIVE 5-YEAR IN-LICENSE AGREEMENT WITH VENTURE LIFE GROUP PLC
Reuters · 04/16 12:34
More
Webull provides a variety of real-time JAGX stock news. You can receive the latest news about Jaguar Health Inc through multiple platforms. This information may help you make smarter investment decisions.
About JAGX
Jaguar Health, Inc. is a commercial-stage pharmaceuticals company. The Company is focused on developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for people and animals with gastrointestinal distress. It operates through two segments: human health and animal health. The animal health segment is focused on developing and commercializing prescription and non-prescription products for companion and production animals. The human health segment is focused on developing and commercializing of human products and the ongoing commercialization of Mytesi, which is used for the symptomatic relief of non-infectious diarrhea in adults with human immunodeficiency virus (HIV)/ acquired immunodeficiency syndrome (AIDS) on antiretroviral therapy. The Canalevia-CA1 is for the treatment of chemotherapy-induced diarrhea (CID) in dogs. Its subsidiary Napo Pharmaceuticals, Inc. focuses on developing and commercializing human prescription pharmaceuticals.